We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2010 17:47 | Are you really heavily invested here Willie, Sub's? You seem to maintain an avid interest, ,you don't need to admit anything or reply, just curious you see, nothing else. Dust those clubs off Willie, long weekend and all that. Personally I prefer to stay home at such times. | mark30 | |
30/4/2010 08:25 | Substp Cash call took 15 days. | willib2 | |
15/4/2010 20:51 | Well someone has to pay to have Evie pushed into the American market ..... As long as it doesn't end up like Ebiox or Optiscope or .......... | substp | |
15/4/2010 15:26 | Substp. Wonder how long before a cash call. | willib2 | |
15/4/2010 12:15 | I'm surprised that he and Moore aren't sharing a condo in Florida ..... | substp | |
15/4/2010 12:13 | Hey Wilburt doesn't TomKing realise that they are all part of the crew on board the HMS Scam ???????..........Let me guess .......mmmmmmmm..... But I'm sure he'll be LURKING in the background sharing stories .....:-) | substp | |
13/4/2010 17:40 | Very sorry Tomking2, but 2 of my friends have already had a good tonking. | willib2 | |
13/4/2010 17:05 | If you are interested in quizzing management, the company is exhibiting at this show in April: www.masterinvestor.c | tomking2 | |
09/4/2010 07:33 | Tudor Cay Condos Secretary and landscaping ? Very comfortable now ...... :-) | substp | |
07/4/2010 18:53 | LOL just like Ebiox huh ....... :-)) I wonder if they ever got their testing right ????? | substp | |
07/4/2010 18:35 | Wow, this looks good. FDA approval. Option to invest into more of the company. (You dont often hear of that). Distribution agreement discussions. How many States are there. And that nice Mr Wray involved. I would think this could be very successful as they have F-----D a lot of people in the past and made money. (For Them). Suziesplodge sounds a much more marketable/impact than "Evie". | willib2 | |
07/4/2010 18:08 | We are fodder Opto, always was, always will be with this shower! Enter Willie boy lol | mark30 | |
07/4/2010 09:08 | But looking at a positive side...we have all helped to keep the 'management' in a job with a good salary, so all our money has no doubt been put to good use giving them a nice lifestyle with plenty of holidays abroad:-))....and look at the tax loss to offset against our capital gains....err, not sure where they are though ;-/ | optomistic | |
07/4/2010 08:51 | mine is worth 248p..beatcha | suziesplodge | |
07/4/2010 08:29 | Wind taken out of my sales when having read the good news I checked my account to see that HCEG have managed to turn £3k into 8 shares worth £2.40 !! That's magic! | johnny felopez | |
07/4/2010 07:53 | Taken from Healthcare Enterprise website - extract: The World Health Organization estimates there are 60 to 80 million infertile couples worldwide. In the U.S., approximately six million couples or 10% of couples of childbearing age are clinically infertile and expenditures relating to fertility services are in excess of $2 billion each year. RSL estimates the world market for fertility services to be approaching $5 billion. The incidence of infertility has been rapidly growing in the developed world. A demographic shift toward the deferral of marriage and first birth has increased the age at which women are first having children. In the U.S., one in every five women now delay attempts to conceive until after they are 35 years of age and studies have shown that a 35-year-old woman is almost three times as likely to be infertile as a woman of 25. | pre | |
07/4/2010 07:41 | extract from today's rns which makes very interesting reading: Highlights: · FDA approval received · European CE approval for the final model received in March 2010 · Manufacturing & assembly agreement signed with Catheter Research, Inc of Indianapolis, Indiana, USA · Discussions underway to appoint US and international distributors with the aim of commencing sales later in 2010 | pre | |
07/4/2010 07:37 | Roll out of product across the world to enhance pregnancy rates...mass market imo...the potential must be huge... | pre | |
07/4/2010 07:10 | back up towards 80p from here now?? Wow!! Fertiligent medical device receives FDA approval TIDMHCEG RNS Number : 7916J Healthcare Enterprise Group PLC 07 April 2010 ? 07 April 2010 Healthcare Enterprise Group PLC (AIM: HCEG) ("Healthcare Enterprise" or the "Group") Fertiligent medical device receives FDA approval Healthcare Enterprise, an international healthcare group, is pleased to announce that Reproductive Sciences Limited ("RSL" or "the Company"), in which it holds a 27% interest, has reported that its Fertiligent artificial insemination device has received formal approval from the US Food and Drugs Administration ("FDA") for its sale in the United States. Highlights: · FDA approval received · European CE approval for the final model received in March 2010 · Manufacturing & assembly agreement signed with Catheter Research, Inc of Indianapolis, Indiana, USA · Discussions underway to appoint US and international distributors with the aim of commencing sales later in 2010 RSL holds the worldwide sales and marketing rights to Fertiligent's products, including the "Evie" device. HCEG has contributed management oversight to RSL, with direct private investment from funders including Nigel Wray. RSL has focussed on Fertiligent's "Evie" product, a high quality, low cost intrauterine sperm pump to help assist infertile couples conceive. From initial trials conducted in Germany and Israel, Fertiligent offers infertile couples an enhanced intrauterine insemination success rate and the chance of avoiding invasive and costly artificial reproductive techniques such as in vitro fertilisation. The Company, RSL, owns 45% of the issued capital in the Israeli Fertiligent Limited company, with options to increase that holding to 78% of the fully diluted capital. RSL also owns the exclusive, worldwide sales & marketing rights to the Israeli Fertiligent company's products. Lyndon Gaborit, Executive Deputy Chairman of Healthcare Enterprise, commented: "We are delighted that this critical milestone has been achieved for the Fertiligent 'Evie' medical device. FDA approval, and the recently received CE approval for the final production version, significantly reduces risk and paves the way for a roll out of this exciting product around the world. Women's reproductive health is a significant and increasing market and this new product, which provides couples with a low cost alternative to existing reproduction methods such as IVF, should, we believe, find good market acceptance with associated returns to RSL's investors, including HCEG." For further information, please contact: +------------------- | Healthcare Enterprise Group PLC | | | | Lyndon Gaborit | Tel: +44 (0)20 7680 | | | | 3649 | | +------------------- | Daniel Stewart & Company plc | Tel + 44 (0)20 7776 6550 | | Andrew Edwards/Emma Earl | | | | | +------------------- | Bishopsgate Communications | | | | Robyn Samuelson / Giang Nguyen | Tel: +44 (0)20 7562 | | | | 3355 | | | | | | +------------------- Note to Editors Healthcare Enterprise Healthcare Enterprise Group PLC (HCEG) is a healthcare investment group which invests in synergistic products and services within the healthcare industry. It currently has two main investments: · Ebiox Limited - Patented decontamination and disinfectant products that are safe and alcohol free but substantially more effective than conventional methods at destroying embedded microorganisms. The Ebiox range includes hand hygiene products, surface disinfectants and products to clean and decontaminate surgical instruments. HCEG owns 20% of Ebiox Limited. · Reproductive Sciences Limited - Innovative slow release pump for intrauterine insemination, proven to significantly enhance pregnancy success rates. HCEG owns 27% of the Company. This information is provided by RNS The company news service from the London Stock Exchange END MSCUGUUWCUPUGBQ | pre | |
12/3/2010 20:22 | Mark30. Good to see you holding back with your forecasts, looks like my time was well spent with you afterall. Ha ha ha. | willib2 | |
08/3/2010 20:32 | But what do I know willie eh, booger all before you start :0) | mark30 | |
08/3/2010 20:23 | Fundamentals look good, very good in fact. 'AT' trades can be used to manipulate things (look it up) You cant really blame Pace for the 'up yours' attitude to the market given the.. err never mind eh! Lets not go there ! Fact is, they've turned this round to be number two on the world stage. That MUST deserve some credit. Frankly I'd be happy for them to stay No 2 Being number one brings on too many pressures to stay there! It's a remarkable story when you look back. | mark30 | |
08/3/2010 20:12 | Got plenty already, cant believe whats going on. Beats me how it got to 240p on potential news then got nuked on the actual news. | willib2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions